Boehringer, Teva Fight Humana's Bid To Block Aggrenox Deal
Boehringer Ingelheim and Teva Pharmaceutical urged a Connecticut federal judge Monday to ignore objections raised by Humana to a $54 million settlement reached with a proposed class of indirect Aggrenox buyers...To view the full article, register now.
Already a subscriber? Click here to view full article